PHARMACEUTICALS: GAO Outlines Skyrocketing Drug Price Pattern
Feds analyze pair of pharmacy assistance programs for report.As the federal government takes on more of the country's drug cost burdens under Medicare Part D and pharmaceutical companies continue to raise their prices, providers could find themselves caught within a cost-cutting tug-of-war.
Report Reveals U&C Price Tags
In a study released on Sept. 15, the Government Accountability Office says that drug prices skyrocketed from January 2000 to December 2004. The GAO obtained the usual and customary prices from two state pharmacy assistance programs and reviewed the pricing trends of 96 drugs that Medicare and non-Medicare Blue Cross...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: